U.S. markets open in 5 hours 12 minutes
  • S&P Futures

    4,532.75
    +8.50 (+0.19%)
     
  • Dow Futures

    34,975.00
    +65.00 (+0.19%)
     
  • Nasdaq Futures

    15,082.25
    +48.75 (+0.32%)
     
  • Russell 2000 Futures

    2,058.80
    -0.40 (-0.02%)
     
  • Crude Oil

    86.34
    -0.62 (-0.71%)
     
  • Gold

    1,840.90
    -2.30 (-0.12%)
     
  • Silver

    24.18
    -0.05 (-0.19%)
     
  • EUR/USD

    1.1353
    +0.0006 (+0.06%)
     
  • 10-Yr Bond

    1.8270
    0.0000 (0.00%)
     
  • Vix

    23.47
    +0.68 (+2.98%)
     
  • GBP/USD

    1.3632
    +0.0020 (+0.15%)
     
  • USD/JPY

    114.2140
    -0.1390 (-0.12%)
     
  • BTC-USD

    41,877.65
    +382.19 (+0.92%)
     
  • CMC Crypto 200

    994.60
    -0.15 (-0.01%)
     
  • FTSE 100

    7,583.05
    -6.61 (-0.09%)
     
  • Nikkei 225

    27,772.93
    +305.70 (+1.11%)
     

South Africa's Aspen in advanced talks over COVID-19 vaccine deal

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

JOHANNESBURG, Nov 29 (Reuters) - Aspen Pharmacare is in advanced discussions over a potential licensing agreement to package the COVID-19 vaccine in South Africa, it said on Monday.

Aspen did not mention the name of the company with which it was in talks, but in early September it said it was in talks with U.S. pharma giant Johnson & Johnson over a vaccine packaging licence.

Aspen currently packages J&J's COVID-19 vaccine at its South African plant under contract, which means it does not have any pricing or distribution power over the product.

(Reporting by Promit Mukherjee Editing by David Goodman)